
Iambic Therapeutics Inc.
IAMNASDAQTechnologySoftware - Application
最新資料
US$23.31
+US$4.40 · +23.27%
IAM公司概覽
公司概況
Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.










